Olympus Innovation Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms.
AI & Machine LearningDigital HealthHealthtechMedical DevicesAuckland, NZ
Greg O'Grady(Founder)inArmen Gharibans(Founder)inKaren O'Regan(CBO)inCraig Shannon(CTO)inChristie Dunwoodie(CFO)inChristopher Andrews(CMO)
Co-investorsBooster Innovation FundCerity Partners VenturesGD1MatūMovacIcehouse Ventures+1 more
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in
Co-investorsAlumni VenturesCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcWindham Capital Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












